Physical Causes of APSD Changes in Aerosols from OIPs and Their Impact on CI Measurements - Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products - page 77

36. Peart J, Kulphaisal P, Orban JC (2003) Relevance of electrostatics in respiratory drug delivery.
Business Briefing: Pharmagenerics, 84-87
37. Mitchell JP, Coppolo DP, Nagel MW (2007) Electrostatics and inhaled medications: influence on
delivery via pressurized metered-dose inhalers and add-on devices. Respir Care 52(3):283-300
38. Bonam M, Christopher D, Cipolla D, Donovan B, Goodwin D, Holmes S, Lyapustina S,
Mitchell J, Nichols S, Petterson G, Quale C, Rao N, Singh D, Tougas T, Van Oort M, Walther
B, Wyka B (2008) Minimizing variability of cascade impaction measurements in inhalers and
nebulizers. AAPS PharmSciTech 9(2):404-413
39. Rau JL, Ari A, Restrepo RD (2004) Performance comparison of nebulizer designs: constant-
output, breath-enhanced, and dosimetric. Respir Care 49(2):174-197
40. Knoch M, Keller M (2005) Ultrasonics, mechanical pressure through ultrafine orifices (SMIs)
or by applying mechanical vibration. Expert Opin Drug Deliv 2(2):377-390
41. Denyer J, Nikander K, Smith NJ (2004) Adaptive aerosol delivery (AAD) technology. Expert
Opin Drug Deliv 1(1):165-176
42. Kesser KC, Geller DE (2009) New aerosol delivery devices for cystic fibrosis. Respir Care
54(6):754-768
43. Lefebvre AH (1989) Atomization and sprays. Hemisphere, New York
44. Nerbrink O, Dahlbäck M, Hansson HC (1994) Why do medical nebulizers differ in their output
and particle characteristics? J Aerosol Med 7:259-276
45. Niven RW, Hickey AJ, Niven RW, Hickey AJ (2007) Atomization and nebulizers. In: Hickey
AJ (ed) Inhalation aerosols, 2nd edn. Informa HealthCare USA, NY, pp 253-283
46. Berg E, Picard RJ (2009) In vitro delivery of budesonide from 30 jet nebulizer/compressor
combinations using infant and child breathing patterns. Respir Care 54(12):1671-1678
47. Dennis JH (2007) Nebulizer efficiency: modeling versus in vitro testing. Respir Care
52(8):984-988
48. Finlay WH, Stapleton KW (1999) Undersizing of droplets from a vented nebulizer caused by
aerosol heating during transit through an Andersen impactor. J Aerosol Sci 30(1):105-109
49. European Directorate for the Quality of Medicines and Healthcare (EDQM) (2012)
Preparations for nebulisation. Section 2.9.44 - European Pharmacopoeia
50. Dennis J, Berg E, Sandell D, Ali A, Lamb P, Tservistas M, Karlsson M, Mitchell J (2008)
Cooling the NGI - an approach to size a nebulised aerosol more accurately. PharmEur Sci
Notes 1:27-30
51. Hinds WC (1993) Physical and chemical changes in the particulate phase. In: Willeke K,
Baran PA (eds) Aerosol measurement: principles, techniques and applications. Van Nostrand
Reinhold, NY, pp 41-53
52. Lee KW, Chen H (1984) Coagulation rate of polydisperse particles. Aerosol Sci Technol
3(3):327-334
53. Finlay WH (2001) The mechanics of inhaled pharmaceutical aerosols: an introduction.
Academic, London, UK
54. Di Benedetto G, Clarke SW (1992) Inhalation therapy in asthma. J R Soc Med 85:3-5
55. Zhou Y, Sun J, Cheng Y-S (2011) Comparison of deposition in the USP and physical mouth-
throat models with solid and liquid particles. J Aerosol Med Pulm Drug Deliv 24(6):277-284
56. Rader DJ, Marple VA (1985) Effect of ultra-Stokesian drag and particle interception on impac-
tor characteristics. Aerosol Sci Technol 4(2):141-156
57. Cheng Y-S, Yazzie D, Zhou Y (2001) Respiratory deposition patterns of salbutamol MDI with
CFC and HFA-134a formulations in a human airway replica. J Aerosol Med 14(2):255-266
58. Zhang Y, Finlay WH (2005) Experimental measurements of particle deposition in three proxi-
mal lung bifurcation models with an idealized mouth-throat. J Aerosol Med 18(4):460-473
59. Martonen TB, Lowe J (1983) Assessment of aerosol deposition patterns in human respiratory
tract casts. In: Marple VA, Liu BYH (eds) Aerosols in the mining and industrial work environ-
ments, vol 1, Fundamentals and Status. Ann Arbor Science, Ann Arbor, MI, pp 151-164
60. Mitchell JP, Poochikian G, Hickey AJ, Suggett J, Curry P, Tougas T (2011) In vitro assessment
of spacers and valved holding chambers used with pressurized metered-dose inhalers: the need